Background Pulmonary cachexia is common in advanced chronic obstructive pulmonary
disease (COPD), culminating in exercise intolerance and a poor prognosis. Ghrelin is a novel …

The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the
standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). …

Background: Multidrug therapy is essential for preventing respiratory failure in patients with
highly progressive Mycobacterium avium complex pulmonary disease (MAC-PD). However, …

Take-home summary Personalized pulmonary rehabilitation including occupational therapy
improves the prognosis of patients with advanced COPD. Purpose We previously reported …

Cancer metastasis is tightly regulated by the interaction of tumor cells and host organ
microenvironments. Matrix metalloproteinases (MMPs), produced by both tumor cells and host …

The diagnosis of Mycobacterium avium complex pulmonary disease (MAC-PD) is sometimes
complicated and time-consuming. A serodiagnostic kit that measures the serum levels of …

Background Although cavities are an important finding in Mycobacterium avium complex
pulmonary disease (MAC-PD), there is little information regarding the types of cavities that …

BACKGROUND: Patients with COPD have reduced exercise tolerance associated with
dyspnea. This exercise intolerance is primarily due to impaired ventilatory mechanics, but it is …

Purpose Pharmacological therapy and pulmonary rehabilitation are useful for exertional
dyspnoea in patients with chronic obstructive pulmonary disease (COPD); however, several …

Objective No studies have demonstrated the real-world efficacy of antifibrotics for progressive
fibrosing interstitial lung disease (PF-ILD). Therefore, we evaluated the efficacy of …